Table 5.
Characteristics of patient exhibiting an objective response
| Patient | Age (yr)/Sex | Site of tumor | Type | Response Duration (mo) |
|---|---|---|---|---|
| a | 48/M | Lung | CR | 6 |
| b | 51/M | Lung | PR | 6 |
| Subcutaneous | ||||
| c | 44/M | Lymph node | PR | 2+ |
| Lung | ||||
| Subcutaneous | ||||
| Cutaneous | ||||
| d | 45/F | Lymph node | PR | 4 |
| Bone | ||||
| Subcutaneous | ||||
| e | 42/F | Cutaneous | PR | 7+ |
| Subcutaneous | ||||
| Liver | ||||
| f | 41/F | Lung | PR | 5+ |
| g | 39/M | Lung | PR | 6 |
| h | 22/F | Lung hilum | PR | 5 |
| i | 48/M | Cutaneous | PR | 6 |
| j | 43/M | Subcutaneous | PR | 5+ |
| k | 42/F | Lung | PR | 2 |
| Lymph node | ||||
| Liver | ||||
| Brain | ||||
| l | 47/F | Lung | PR | 5+ |
| Lymph node | ||||
| m | 59/M | Subcutaneous | PR | 3+ |